NESNCHF 86.40-1.68%NOVNCHF 108.60-2.15%ROGCHF 278.40-0.23%GDAXI€25,427-0.58%FTSE£10,609-1.87%FCHI€8,122.53-2.35%STOXX50E€6,267.26-0.70%SSMICHF 13,759-2.13%AEX€1,096.43-1.76%IBEX€19,638-1.80%FTSEMIB.MI€51,784-0.75%NESNCHF 86.40-1.68%NOVNCHF 108.60-2.15%ROGCHF 278.40-0.23%GDAXI€25,427-0.58%FTSE£10,609-1.87%FCHI€8,122.53-2.35%STOXX50E€6,267.26-0.70%SSMICHF 13,759-2.13%AEX€1,096.43-1.76%IBEX€19,638-1.80%FTSEMIB.MI€51,784-0.75%
Roche (ROG)
SIX · CHF
CHF 278.40-0.23% (CHF -0.65)
Market open · Last known quote: Sep 10, 2026, 6:27 PM GMT+0530
Previous CloseCHF 279.05
OpenCHF 280.35
Day's RangeCHF 277.01 - CHF 282.04
52 Week RangeCHF 180.55 - CHF 388.14
Volume3.93M
Avg. Volume3.20M
Market CapCHF 222.72B
Beta (5Y Monthly)1.59
PE Ratio (TTM)N/A
EPS (TTM)N/A
Forward Dividend & YieldN/A
1y Target EstN/A
People also watch
BHP GroupBHP£3,233.00-4.94%
Rio TintoRIO.L£7,327.00-3.62%
BPBP.L£572.10+2.69%
ASML HoldingASML€1,460.00-2.51%
ASML HoldingASML.AS€1,460.00-2.51%
NovartisNOVNCHF 108.60-2.15%
NovartisNOVN.SWCHF 108.60-2.15%
ShellSHEL.L£3,574.00+2.00%
HSBCHSBA.L£1,522.80-1.70%
NestléNESNCHF 86.40-1.68%
NestléNESN.SWCHF 86.40-1.68%
LVMHMC€648.20-1.58%
AirbusAIR€178.60-1.54%
UniCreditUCG€83.18-1.23%
SanofiSAN€98.60+1.19%
VolkswagenVOW3€98.60-1.08%
Related in Drug Manufacturers—General
NovartisNOVNCHF 108.60-2.15%
NovartisNOVN.SWCHF 108.60-2.15%
RocheROG.SWCHF 278.40-0.23%
AstraZenecaAZN.L£11,578-0.62%
SanofiSAN€98.60+1.19%
Johnson & JohnsonJNJ$270.61+1.32%
Eli LillyLLY$1,132.37+0.73%
AbbVieABBV$252.00+0.43%
MerckMRK$148.10+0.39%
PfizerPFE$27.88+0.36%
AmgenAMGN$389.78-0.38%
Gilead SciencesGILD$146.59+0.65%
About Roche
F. Hoffmann-La Roche AG, commonly known as Roche (), is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest…
Founded byFritz Hoffmann-La Roche
From the companyWe unite leading science and technology across diagnostics, medicines, and digital solutions to prevent, stop and cure diseases.
Financial statistics
Valuation Measures
| Market Cap | CHF 222.72B |
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio | N/A |
| Price/Sales | N/A |
| Price/Book | N/A |
Financial Highlights
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | 3.20M |
| Shares Outstanding | 800.00M |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
Technical analysis
Summary
Neutral
Last price is below the short and medium moving averages. RSI 69.1, MACD negative. Trend: sideways.
TrendSideways
RSI (14)69.1
MACD-0.108
SMA 20CHF 277.94
SMA 50CHF 278.26
SMA 200CHF 278.49
SupportCHF 277.67
ResistanceCHF 278.57
Stochastic %K93.6
ATR (14)0.185
| Indicator | Call | Detail |
|---|---|---|
| Price vs SMA 20 | Buy | Last close is above the 20-session average. |
| Price vs SMA 50 | Buy | Medium-term trend is still up. |
| SMA cross | Sell | The 20-session average is below the 50-session average. |
| RSI (14) | Neutral | RSI is in the mid-range. |
| MACD | Sell | MACD line is below zero. |
| Stochastic | Sell | Stochastic %K is overbought. |
Company profile
SectorHealthcare
IndustryDrug Manufacturers—General
Employees103,611
CEOThomas Schinecker
HeadquartersBasel
CountrySwitzerland
Founded1 Oct 1896
Legal formAktiengesellschaft
OrganisationSwiss healthcare company
Website
www.roche.com
Key management
- Thomas Schinecker Chief Executive Officer
Historical price data
Currency in CHF| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Loading recent price history | |||||
News & official updates
TechGraph News · 2024-08-13
Best Agrolife Ltd. Reports INR 519.3 Crore Revenue for FY25, Announces Continued Focus Towards Building Branded Business
TechGraph News · 2024-07-25
Best Agrolife Limited Announces Steady FY24 Growth and Marks New Chapter with NSE Listing
TechGraph News · 2023-11-30
Best Agrolife Acquires 99% Stake in Kashmir Chemicals; Becomes Major Partner
TechGraph News · 2023-11-08
Q2 FY24 Revenue Jumps 32% QoQ to Rs. 811 Cr
TechGraph News · 2023-10-30
Best Agrolife Secures Key 20-Year Patent for Revolutionary Herbicidal Composition to Boost Rice Yields
TechGraph News · 2023-10-18
Best Agrolife Hosts Successful North Karnataka Dealer Meeting at Sindhanur; Introduces its Cutting Edge Product, Tricolor
Price quotes and the 1D chart refresh every few seconds while this page stays open — no reload needed. Last trade is taken from the exchange feed where available; some venues delay 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.